Mangalam Drugs And Organics Share Price
30.64+0.34 (+1.12%)
-59.77% past 1 Year
Mangalam Drugs and Organics Limited is an India-based company engaged in the manufacturing of chemicals such as active pharma ingredients (API) perfumery disperse dye intermediates bulk drugs and bulk drugs
Corporate filings & documents
Announcements
Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September 2026 and information on E-voting.
2 days agoNewspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September 2026 and information on E-voting.
2 days agoIntimation of dispatch of Annual Report for 53rd Annual General Meeting for the financial year 2025-26 to be held on Wednesday September 23rd 2026 to the Shareholders of the Company.
3 days agoIntimation of dispatch of Annual Report for 53rd Annual General Meeting for the financial year 2025-26 to be held on Wednesday September 23rd 2026 to the Shareholders of the Company.
3 days agoAnnual Report of the Company Notice convening 53rd Annual General Meeting for the financial year 2025-26 to be Held on Wednesday September 23rd 2026 and Intimation of Cut-off Date for remote E-voting of the Company.
3 days agoAnnual Report of the Company Notice convening 53rd Annual General Meeting for the financial year 2025-26 to be Held on Wednesday September 23rd 2026 and Intimation of Cut-off Date for remote E-voting of the Company.
3 days agoIntimation of default under Para A sub- paragraph 6 Schedule III-subsequent default
2 weeks agoIntimation of default under Para A sub- paragraph 6 Schedule III-subsequent default
2 weeks agoNewspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026
3 weeks agoNewspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026
3 weeks agoAppointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company
3 weeks agoAppointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company
3 weeks agoAppointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.
3 weeks agoAppointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.
3 weeks agoDeclaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
3 weeks agoDeclaration of Un-audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
3 weeks agoOutcome of Board meeting held on 12th August 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
3 weeks agoOutcome of Board meeting held on 12th August 2026 interalia for approval of Un-Audited Financial results (Standalone & Consolidated) for the quarter ended 30th June 2026
3 weeks agoIntimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.
4 weeks agoIntimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.
4 weeks agoMangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.
4 weeks agoMangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.
4 weeks agoIntimation of subsequent default under Para A sub-paragraph 6 of Schedule III
1 month agoIntimation of subsequent default under Para A sub-paragraph 6 of Schedule III
1 month agoIntimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III
1 month agoIntimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III
1 month agoIntimation regarding certificate received from Registrar and Transfer agent under Regukation 74(5) of SEBI (DP) Regulations 2018
1 month agoIntimation regarding certificate received from Registrar and Transfer agent under Regukation 74(5) of SEBI (DP) Regulations 2018
1 month agoIntimation of closure of trading Window for the period ended 30th June 2026
2 months agoIntimation of closure of trading Window for the period ended 30th June 2026
2 months agoDisclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
2 months agoDisclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
2 months agoDisclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
2 months agoDisclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.
2 months agoSubsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations 2015 of default of Bank Loan account.
2 months agoSubsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations 2015 of default of Bank Loan account.
2 months agoSubmission of Annual Secretarial Compliance Report for the period ended 31st March 2026
3 months agoAnnual Secretarial Compliance Report to be filed for the financial year ended March 31 2026 as per Regulation 24A of SEBI LODR 2025.
3 months agoAnnual Secretarial Compliance Report to be filed for the financial year ended March 31 2026 as per Regulation 24A of SEBI LODR 2025.
3 months agoDisclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.
3 months agoDisclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.
3 months agoDisclosure of notice of postal ballot /E- Voting seeking shareholders approval pursuant to Regulation 30 of SEBI LODR 2015 . for reappointment of Shri Praveen Saxena as an Independent Director DIN: 03199264 of the Company for second term of 5 consective years. The Evoting shall commence from 19.05.2026 (9:00 am) and will end on 17.06.2026 (5:00 pm).
3 months agoIntimation of subsequent default of Bank under Para A sub-paragraph 6 of Schedule III-Subsequent default
3 months agoIntimation of subsequent default of Bank under Para A sub-paragraph 6 of Schedule III-Subsequent default
3 months agoNewspaper Publication for declaration of Annual Financial Results (Consolidated and Standalone) for the quarter and financial year ended March 31 2026.
3 months agoNewspaper Publication for declaration of Annual Financial Results (Consolidated and Standalone) for the quarter and financial year ended March 31 2026.
3 months agoApproval of Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March 2026
3 months agoOutcome of Board Meeting held on 14th May 2026 for declaration of Audited Financial Results (Standalone & Consolidated) of the Company for the period ended 31st March 2026
3 months agoMangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Intimation of Board meeting to be held on 14th May 2026 inter-alia to approve Audited Financial results (Standalone & Consolidated)of the Company for the period ended 31st March 2026
4 months agoMangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Intimation of Board meeting to be held on 14th May 2026 inter-alia to approve Audited Financial results (Standalone & Consolidated)of the Company for the period ended 31st March 2026
4 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2024-03-15
Merger
Merger
2017-12-21
Dividend
0.5
Company details
Registered office
‘3” Floor 239, Rupam Building P. D. Mello Road, Near G P O Mumbai Maharashtra PIN: 400001 Tel No: 022-22616200 / 6300 / 8787 Fax No: 022-2619090 Email: [email protected] Internet: www.mangalamdrugs.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Govardhan M Dhoot, Chairman & Managing Director
Govardhan M Dhoot, Chairman & Managing Director
Brijmohan Dhoot, Whole Time Director
Nidhi Mundada, Non Executive Independent Director
Praveen Saxena, Non Executive Independent Director
Rakesh K Milwani, Non Independent & Non Executive Director
Shweta Patel, Company Secretary & Compliance Officer
Details
BSE 532637
NSE MANGALAM
ISIN INE584F01014